Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • anle
    Junior Member
    • Mar 2011
    • 7

    RNA seq analysis with one replicate per biological sample

    Hi, I am new in the field of deep sequencing analysis and for the past two months I am struggling to understand RNA seq differential expression studies.
    I have 1 control sample and 1 sample for each of the three different experimental conditions. No technical replicates. So I guess I cannot apply some GLM approach or estimate mean and variances from the replicates.
    I chose to normalize with applying a simple linear correction after fiiting the log # of reads ( condition x vs control) and then to calculate the significance of the Differential expression by calculating a z score for each gene by using my control sample to estimate per gene mean and variance (which have practically the same values). The p values that I get are extremely low even after bonferoni correction (eg top 1000 pvalue still less 1e-100). This is quite counter intuitive for interpretation. Any other suggestions for better normalizing or studying DE?? thanks
  • Cole Trapnell
    Senior Member
    • Nov 2008
    • 213

    #2
    How many genes do you expect to be differentially expressed? If that number is a small fraction of the total (say 10% - others may have better guidance and experience in this situation), you can treat your conditions as replicates to model the biological variability in fragment counts as a function of expression level. Cuffdiff (1.0 and later) and I believe both DESeq and edgeR can do this.

    When you give Cuffdiff samples from three conditions, and each has only a single replicate, Cuffdiff looks at the mean fragment count in each locus across replicates, calculates the variance at each locus, and fits a model of fragment variability across replicates. This same model of variability is used for each of the three conditions during differential expression testing. Because the the genuinely differentially expressed genes are going to amplify the variance, the model will predict more variance than really exists. However, if the number of differentially expressed genes is small, the overestimation of variability will be small. It's not an ideal situation, but its better than no empirical model of variability at all. Had you replicates in each condition, Cuffdiff would fit a model of variability for each condtion and use the appropriate models during testing.

    So the short version of my suggestion is just to try Cuffdiff - it will do the above by default with your data.

    Comment

    • para_seq
      Member
      • Aug 2009
      • 12

      #3
      Hi, Cole,

      Thank you for the explanation. Do I understand it correct that the variance value empirically estimated by cuffdiff, DESeq, and edgeR is gene-specific, i.e. different genes will have different variance values? If the answer is yes, how does the relative number of differentially expressed genes out of the total genes has any effect on how good (or bad) the test for DE would be? Does the variance value get somehow normalized across read count of all genes?

      Thank you.


      Ben

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Nine Things a Sample Prep Scientist Thinks About Before Sequencing
        by SEQadmin2


        I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.


        Here are nine questions we think about, in roughly the order they matter, before...
        Today, 07:11 AM
      • SEQadmin2
        From Collection to Sequencing: Why Sample Preparation and Preservation Define Sequencing Data
        by SEQadmin2


        Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.


        The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
        ...
        06-02-2026, 10:05 AM
      • SEQadmin2
        Single-Cell Sequencing at an Inflection Point: Early Impacts of New Platforms and Emerging Trends
        by SEQadmin2


        With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.


        Introduction

        Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...
        05-22-2026, 06:42 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 06:09 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 06-09-2026, 11:58 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 06-05-2026, 10:09 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 06-04-2026, 08:59 AM
      0 responses
      49 views
      0 reactions
      Last Post SEQadmin2  
      Working...